Chapter 4 Interactions of Chemokines with Glycosaminoglycans

Methods in Enzymology

Volumn 461, Issue B, 2009, Pages 71-102

  Hamel, Damon J ^a   Sielaff, India ^b   Proudfoot, Amanda E I ^b   Handel, Tracy M ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b MERCK SERONO S A   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; EPITOPE; GLYCOSAMINOGLYCAN;

DEUTERIUM HYDROGEN EXCHANGE; FLUORESCENCE; HETERONUCLEAR SINGLE QUANTUM COHERENCE; IN VIVO STUDY; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; MASS SPECTROMETRY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; REVIEW; SEDIMENTATION; SURFACE PLASMON RESONANCE; ULTRACENTRIFUGATION;

ANIMALS; CHEMOKINES; CHROMATOGRAPHY, AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSAMINOGLYCANS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICE; PROTEIN BINDING; PROTEIN CONFORMATION; SURFACE PLASMON RESONANCE;

ANIMALIA;

EID: 65749093488     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)05404-4     Document Type: Review

References (61)

1. Alexander J.M., Nelson C.A., van Berkel V., Lau E.K., Studts J.M., Brett T.J., Speck S.H., Handel T.M., Virgin H.W., and Fremont D.H. Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 111 (2002) 343-356
2. Alexander-Brett J.M., and Fremont D.H. Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor. J. Exp. Med. 204 (2007) 3157-3172
3. Ali S., Robertson H., Wain J.H., Isaacs J.D., Malik G., and Kirby J.A. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation. J. Immunol. 175 (2005) 1257-1266
4. Amara A., Lorthioir O., Valenzuela A., Magerus A., Thelen M., Montes M., Virelizier J.L., Delepierre M., Baleux F., Lortat-Jacob H., and Arenzana-Seisdedos F. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J. Biol. Chem. 274 (1999) 23916-23925
5. Balbo A., Brown P.H., Braswell E.H., and Schuck P. Measuring protein-protein interactions by equilibrium sedimentation. Curr. Protoc. Immunol. 18 (2007) 188
6. Balbo A., Brown P.H., Braswell E.H., and Schuck P. Measuring protein-protein interactions by equilibrium sedimentation. Curr. Protoc. Immunol. 18 (2007) 188
7. Braunersreuther V., Steffens S., Arnaud C., Pelli G., Burger F., Proudfoot A., and Mach F. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 1090-1096
8. Campanella G.S., Lee E.M., Sun J., and Luster A.D. CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10). J. Biol. Chem. 278 (2003) 17066-17074
9. Charvatova O., Foley B.L., Bern M.W., Sharp J.S., Orlando R., and Woods R.J. Quantifying protein interface footprinting by hydroxyl radical oxidation and molecular dynamics simulation: Application to galectin-1. J. Am. Soc. Mass Spectrom. 19 (2008) 1692-1705
10. Crown S.E., Yu Y., Sweeney M.D., Leary J.A., and Handel T.M. Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding. J. Biol. Chem. 281 (2006) 25438-25446
11. Das A.M., Flower R.J., and Perretti M. Resident mast cells are important for eotaxin-induced eosinophil accumulation in vivo. J. Leukoc. Biol. 64 (1998) 156-162
12. Deruaz M., Frauenschuh A., Alessandri A.L., Dias J.M., Coelho F.M., Russo R.C., Ferreira B.R., Graham G.J., Shaw J.P., Wells T.N., Teixeira M.M., Power C.A., et al. Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. J. Exp. Med. 205 (2008) 2019-2031
13. Ellyard J.I., Simson L., Bezos A., Johnston K., Freeman C., and Parish C.R. Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo. J. Biol. Chem. 282 (2007) 15238-15247
14. Falsone S.F., Gesslbauer B., Rek A., and Kungl A.J. A proteomic approach towards the Hsp90-dependent ubiquitinylated proteome. Proteomics 7 (2007) 2375-2383
15. Goger B., Halden Y., Rek A., Mosl R., Pye D., Gallagher J., and Kungl A.J. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: A model for chemokine regulation at inflammatory sites. Biochemistry 41 (2002) 1640-1646
16. Handel T.M., and Domaille P.J. Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer. Biochemistry 35 (1996) 6569-6584
17. Handel T.M., Johnson Z., Crown S.E., Lau E.K., and Proudfoot A.E. Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu. Rev. Biochem. 74 (2005) 385-410
18. Handel T.M., Johnson Z., Rodrigues D.H., dos Santos A.C., Cirillo R., Muzio V., Riva S., Mack M., Déruaz M., Borlat F., Vitte P.-A., Wells T.N.C., et al. An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo. J. Leukoc. Biol. 84 (2008) 1101-1108
19. Hemmerich S., Paavola C., Bloom A., Bhakta S., Freedman R., Grunberger D., Krstenansky J., Lee S., McCarlet D., Mulkins M., Wong B., Pease J., et al. Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. Biochemistry 38 (1999) 13013-13025
20. Herndon M.E., Stipp C.S., and Lander A.D. Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: Assessment of selectivity, heterogeneity and the participation of core proteins in binding. Glycobiology 9 (1999) 143-155
21. Hoogewerf A.J., Kuschert G.S., Proudfoot A.E., Borlat F., Clark-Lewis I., Power C.A., and Wells T.N. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36 (1997) 13570-13578
22. Jarnagin K., Grunberger D., Mulkins M., Wong B., Hemmerich S., Paavola C., Bloom A., Bhakta S., Diehl F., Freedman R., McCarley D., Polsky I., et al. Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2. Biochemistry 38 (1999) 16167-16177
23. Johnson Z., Kosco-Vilbois M.H., Herren S., Cirillo R., Muzio V., Zaratin P., Carbonatto M., Mack M., Smailbegovic A., Rose M., Lever R., Page C., et al. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J. Immunol. 173 (2004) 5776-5785
24. Johnson Z., Proudfoot A.E., and Handel T.M. Interaction of chemokines and glycosaminoglycans: A new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev. 16 (2005) 625-636
25. Kadi L., Selvaraju R., de Lys P., Proudfoot A.E., Wells T.N., and Boschert U. Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro. J. Neuroimmunol. 174 (2006) 133-146
26. Kawashima H., Watanabe N., Hirose M., Atarashi X., Kimura T., Shikata K., Matsuda M., Ogawa D., Haljasvaara R., Rehn M., Pihlajaniemi T., et al. Collagen XVIII, a basement membrane heparan sulfate proteoglycan, interacts with L-selectin and monocyte chemoattractant protein-1. J. Biol. Chem. 278 (2003) 13069-13076
27. Koopmann W., Ediriwickrema C., and Krangel M.S. Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1 beta. J. Immunol. 163 (1999) 2120-2127
28. Koopmann W., and Krangel M.S. Identification of a glycosaminoglycan-binding site in chemokine macrophage inflammatory protein-1 alpha. J. Biol. Chem. 272 (1997) 10103-10109
29. Kuschert G.S.V., Coulin F., Power C.A., Proudfoot A.E.I., Hubbard R.E., Hoogewerf A.J., and Wells T.N.C. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38 (1999) 12959-12968
30. Kuschert G.S.V., Hoogewerf A.J., Proudfoot A.E.I., Chung C.W., Cooke R.M., Hubbard R.E., Wells T.N.C., and Sanderson P.N. Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry 37 (1998) 11193-11201
31. Lalani A.S., Graham K., Mossman K., Rajarathnam K., ClarkLewis I., Kelvin D., and McFadden G. The purified myxoma virus gamma interferon receptor homolog M- T7 interacts with the heparin-binding domains of chemokines. J. Virol. 71 (1997) 4356-4363
32. Lau E.K., Kungl A., Paavola C., Johnson Z., Borlat F., Proudfoot A.E., and Handel T.M. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. J. Biol. Chem. 279 (2004) 22294-22305
33. Lau E.K., Paavola C.D., Johnson Z., Gaudry J.P., Geretti E., Borlat F., Kungl A.J., Proudfoot A.E., and Handel T.M. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: Implications for structure and function in vivo. J. Biol. Chem. 279 (2004) 22294-22305
34. Laurence J.S., Blanpain C., Burgner J.W., Parmentier M., and LiWang P.J. CC chemokine MIP-1: beta can function as a monomer and depends on Phe13 for receptor binding. Biochemistry 39 (2000) 3401-3409
35. Laurence J.S., Blanpain C., De Leener A., Parmentier M., and LiWang P.J. Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions. Biochemistry 40 (2001) 4990-4999
36. Lubkowski J., Bujacz G., Boque L., Domaille P.J., Handel T.M., and Wlodawer A. The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions. Nat. Struct. Biol. 4 (1997) 64-69
37. Mandell J.G., Baerga-Ortiz A., Croy C.H., Falick A.M., and Komives E.A. Application of amide proton exchange mass spectrometry for the study of protein-protein interactions. Curr. Protoc. Protein Sci. 20 (2005) 20-29
38. McCornack M.A., Cassidy C.K., and LiWang P.J. The binding surface and affinity of monomeric and dimeric chemokine macrophage inflammatory protein 1 beta for various glycosaminoglycan disaccharides. J. Biol. Chem. 278 (2003) 1946-1956
39. Osmond R.I., Kett W.C., Skett S.E., and Coombe D.R. Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization. Anal. Biochem. 310 (2002) 199-207
40. Paavola C., Hemmerich S., Grunberger D., Polsky I., Bloom A., Mulkins R., McCarley D., Wiesent L., Wong B., Jarnagin K., et al. Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J. Biol. Chem. 273 (1998) 33157-33165
41. Peterson F.C., Elgin E.S., Nelson T.J., Zhang F., Hoeger T.J., Linhardt R.J., and Volkman B.F. Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin. J. Biol. Chem. 279 (2004) 12598-12604
42. Pinho V., de Castro Russo R., Amaral F.A., de Sousa L.P., Barsante M.M., de Souza D.G., Alves-Filho J.C., Cara D.C., Hayflick J.S., Rommel C., Ruckle T., Rossi A.G., et al. Tissue- and stimulus-dependent role of phosphatidylinositol 3-kinase isoforms for neutrophil recruitment induced by chemoattractants in vivo. J. Immunol. 179 (2007) 7891-7898
43. Proost P., Loos T., Mortier A., Schutyser E., Gouwy M., Noppen S., Dillen C., Ronsse I., Conings R., Struyf S., Opdenakker G., Maudgal P.C., Maudgal P.C., et al. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J. Exp. Med. 205 (2008) 2085-2097
44. Proudfoot A.E.I., Fritchley S., Borlat F., Shaw J.P., Vilbois F., Zwahlen C., Trkola A., Marchant D., Clapham P.R., and Wells T.N.C. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276 (2001) 10620-10626
45. Proudfoot A.E.I., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., Borlat F., Wells T.N.C., and Kosco-Vilbois M.H. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100 (2003) 1885-1890
46. Ramos C.D., Heluy-Neto N.E., Ribeiro R.A., Ferreira S.H., and Cunha F.Q. Neutrophil migration induced by IL-8-activated mast cells is mediated by CINC-1. Cytokine 21 (2003) 214-223
47. Ruiz-Arguello M.B., Smith V.P., Campanella G.S., Baleux F., Arenzana-Seisdedos F., Luster A.D., and Alcami A. An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. J. Virol. 82 (2008) 917-926
48. Sadir R., Baleux F., Grosdidier A., Imberty A., and Lortat-Jacob H. Characterization of the stromal cell-derived factor-1alpha-heparin complex. J. Biol. Chem. 276 (2001) 8288-8296
49. Sasisekharan R., Shriver Z., Venkataraman G., Narayanasami U., Liu D., and Qi Y. Roles of heparan-sulphate glycosaminoglycans in cancer: Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycans. Nat. Rev. Cancer 2 (2002) 521-528
50. Schenauer M.R., Yu Y., Sweeney M.D., and Leary J.A. CCR2 chemokines bind selectively to acetylated heparan sulfate octasaccharides. J. Biol. Chem. 282 (2007) 25182-25188
51. Schuck P. Use of surface plasmon resonance to probe the equilibrium and dynamic aspects of interactions between biological macromolecules. Annu. Rev. Biophys. Biomol. Struct. 26 (1997) 541-566
52. Seyfried N.T., Atwood III J.A., Yongye A., Almond A., Day A.J., Orlando R., and Woods R.J. Fourier transform mass spectrometry to monitor hyaluronan-protein interactions: Use of hydrogen/deuterium amide exchange. Rapid Commun. Mass Spectrom. 21 (2007) 121-131
53. Shriver Z., Liu D., and Sasisekharan R. Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions. Trends Cardiovasc. Med. 12 (2002) 71-77
54. Sielaff I., Gaudry J.P., Johnson Z., Kungl A., Mulloy B., Proudfoot A.E.I., and Handel T.M. Investigation of the glycosaminoglycan binding site of CXCL11/ I-TAC identifies a diffuse and unexpected high affinity site for heparin. J. Biol. Chem. (2009) Submitted to
55. Takamoto K., and Chance M.R. Radiolytic protein footprinting with mass spectrometry to probe the structure of macromolecular complexes. Annu. Rev. Biophys. Biomol. Struct. 35 (2006) 251-276
56. van Berkel V., Barrett J., Tiffany H.L., Fremont D.H., Murphy P.M., McFadden G., Speck S.H., and Virgin H.I. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J. Virol. 74 (2000) 6741-6747
57. Vives R.R., Sadir R., Imberty A., Rencurosi A., and Lortat-Jacob H. A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry 41 (2002) 14779-14789
58. Webb L.M., Ehrengruber M.U., Clark-Lewis I., Baggiolini M., and Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA 90 (1993) 7158-7162
59. Xu G., and Chance M.R. Hydroxyl radical-mediated modification of proteins as probes for structural proteomics. Chem. Rev. 107 (2007) 3514-3543
60. Yu Y., Sweeney M.D., Saad O.M., Crown S.E., Hsu A.R., Handel T.M., and Leary J.A. Chemokine-glycosaminoglycan binding: Specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry. J. Biol. Chem. 280 (2005) 32200-32208
61. Zhuang T., Leffler H., and Prestegard J.H. Enhancement of bound-state residual dipolar couplings: Conformational analysis of lactose bound to Galectin-3. Protein Sci. 15 (2006) 1780-1790